BMS Selling Celgene’s Otezla to Address FTC “Concerns” on $74B Deal
Otezla® (apremilast)
Bristol-Myers Squibb (BMS) plans to divest itself of the psoriasis drug Otezla® (apremilast) as part of its planned $74 billion acquisition of Celgene, in order to address what it called “concerns” raised by...
Promising new technique for high throughput protein purification
Jun 25 2019
Postnova Analytics has published an application report that describes a promising new protein purification technique based on diffusion.
Related Stories
Protein purification is a widely used and important tool for biotechnology labs. Traditionally...
How the dragon got its frill
Studying the developing embryo of the ‘frilled dragon’ lizard, UNIGE researchers reveal that physical forces, rather than a genetic program, generate the characteristic folds of its spectacular collar.
Credit: © UNIGE, A.Debry/S.Montandon/M.Milinkovitch
Scientists develop new, rapid test to diagnose bacterial lower respiratory tract infections
Scientists at the Quadram Institute and the University of East Anglia (UEA) have developed a new, rapid way of diagnosing bacterial lower respiratory tract infections in hours rather than days, that could improve patient...
Turning Drug Delivery Inside Out
David Giljohann, PhD, CEO of Exicure, thought that he had made a mistake during his first year of graduate school when the controls he ran with his experiments gave some unexpected results. As he...
Expedeon AG launches Lightning-Link Metal Labeling Kits to support single cell analysis
Jun 24 2019
Expedeon AG announced today it has introduced Lightning-Link® Metal Labeling Kits for use in multiple immunoassay-based applications to support single cell analysis. The new kits will enable users to dramatically enhance the...
Medovex’s Transition to H-CYTE Underscores Biotechnology Focus – GlobeNewswire
ALPHARETTA, Ga., June 24, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: Symbol MDVX) ("Medovex" or the "Company"), is transitioning to its new name H-CYTE Inc. (“H-CYTE”) to underscore its focus of delivering regenerative anti-inflammatory...
Suicide, accidents, and hepatitis: The leading causes of death for Veterans in their first...
A new study in the American Journal of Preventive Medicine identifies and stratifies the mortality risks by age group, providing valuable insights for guiding prevention and treatment efforts
Credit: Jenna Forehand, MD, MPH
Biotechnology: Friend or foe? – Arab News
Biotechnology: Friend or foe?
Even before the agricultural and industrial revolutions, the term biotechnology applied to many areas of human livelihood dealing with crops, livestock, and other domesticated animals. Thanks to continual scientific advancement,...
Fighting hidden hunger with promising new approach
After a prolonged decline, global hunger is on the rise--affecting more than 820 million individuals in 2017. Additionally, more than 2 billion people suffer from "hidden hunger," which occurs when individuals eat foods that...
